GRIFOLS | GRF - Loan Capital


GRIFOLS reported EUR9.08B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Alcon AG USD 4.16B 434M Mar/2026
Almirall EUR 324.81M 61.32M Dec/2025
Amadeus IT EUR 2.54B 1.8M Mar/2026
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 25.96B 177M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Cie Automotive EUR 1.48B 58.65M Dec/2025
Demant DKK 18.98B 3.71B Dec/2025
Ence Energia y Celulosa EUR 509.58M 6.32M Dec/2025
Essilor EUR 9.46B 92M Dec/2025
Ferrovial EUR 9.36B 816M Dec/2025
Fresenius EUR 9.22B 1.58B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Inditex EUR 4.44B 45M Mar/2026
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Philips EUR 6.89B 43M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Smith & Nephew USD 3.3B 22M Dec/2025
UCB EUR 2.18B 634M Dec/2025
Viscofan EUR 67.83M 19.93M Mar/2026